Drug Database
LE
leuprolide acetate (Leupronax)
✓ ApprovedNanox · GNRH1 · Small Molecule
What is leuprolide acetate?
leuprolide acetate is a small molecule developed by Nanox. It is approved for therapeutic indications via injectable (others) or intramuscular (im) injection.
Drug Profile
| Brand Names | Leupronax |
| Company | Nanox |
| Drug Class | Small Molecule, Polypeptide |
| Molecular Target | GNRH1 |
| Route | Injectable (Others), Intramuscular (IM) Injection |
| Status | Approved |
Sources: ClinicalTrials.gov, Nanox
Mechanism of Action
Molecular Targets
leuprolide acetate acts on 1 molecular target:
| GNRH1 | gonadotropin releasing hormone 1 (GNRH, LHRH) |
Want deeper analysis?Noah AI can explain complex mechanisms and compare to similar drugs.
Therapeutic Indications
leuprolide acetate is developed for 4 unique indications across 2 therapeutic areas.
| Therapeutic Area | Condition | Phase |
|---|---|---|
| Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Breast cancer | ✓ Approved |
| Reproductive system and breast disorders | Endometriosis | ✓ Approved |
| Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Prostate cancer | ✓ Approved |
| Reproductive system and breast disorders | Uterine fibrosis | ✓ Approved |
Related Research Articles
Unable to load articles right now.